Media News

The CDE Approved IND Application to Investigate Combination of Asieris’ APL-1202 and BeiGene’s Tislelizumab as Neoadjuvant Therapy for MIBC Patients

SHANGHAI, Oct. 13, 2021 /PRNewswire/ -- Asieris Pharmaceuticals (Asieris) today announced that the Center for Drug Evaluation (CDE) NMPA has approved the Investigational New Drug (IND) application of oral APL-1202 in combination with BeiGene's tislelizumab as neoadjuvant therapy in patients with muscle invasive bladder cancer (MIBC). This IND was already cleared by the U.S. Food and Drug Administration (FDA)...

Increasing Demand for Premium Dietary Options Fueling the Global Pet Food Ingredients Market

Growing consciousness of pet health and wellness pushes the growth of functional and specialized ingredients SAN ANTONIO, Oct. 13, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis of the global pet food ingredients industry finds that pet owners' growing emphasis on the quality of their pet's diet is inflating the demand for premium pet food. This is driving the global...

World Thrombosis Day Campaign Unites Thousands of Global Partners to Shine a Spotlight on Blood Clots as an Urgent Health Problem

In its Eighth Year, the Global Campaign Aims to Increase Public Awareness of Blood Clots that Result from Hospitalization and COVID-19 CHAPEL HILL, N.C., Oct. 13, 2021 /PRNewswire/ -- Today, the World Thrombosis Day campaign encourages the public, healthcare professionals and policy makers to keep their "Eyes Open to Thrombosis" and join together...

Gilead Sciences Partners with the International AIDS Society to Champion Stigma-free HIV Care Services in Asia and Latin America

SINGAPORE, Oct. 13, 2021 /PRNewswire/ -- Gilead Sciences, Inc. today announced its partnership with IAS - the International AIDS Society - to expand the Me & My Healthcare Provider campaign to three locations in Asia: Hong Kong; South Korea; and Taiwan and renew the program in two locations in Latin America: Brazil and Mexico. The campaign promotes best practices in...

New Dymax MD(R) 1040-M Autoclave Resistant Adhesive for Medical Instruments and Assembly

SINGAPORE, Oct. 13, 2021 /PRNewswire/ -- Dymax Corporation, leading manufacturer of rapid curing materials and equipment, unveils its newest product, 1040-M, as part of its MD® line of adhesives for medical device assembly applications. Designed to be autoclave resistant for more than 100 cycles, MD® 1040-M offers extremely low water absorption (0.5%) making it ideal for surgical tools and...

FII Institute partners with global entities for 5th Anniversary FII

- The Future Investment Initiative (FII) Institute has announced 16 partnerships with Saudi and international companies and entities for the 5th Anniversary of FII on October 26 – 28, 2021 - Global partners include BNY Mellon, HSBC, Reliance Industries and Softbank Vision Fund RIYADH, Saudi Arabia, Oct. 13, 2021 /PRNewswire/ -- The Future Investment Initiative (FII) Institute is...

SOPHiA GENETICS offers new genomic application for a deeper investigation of Mendelian diseases

SOPHiA Clinical Exome Solution v3 offers a streamlined end-to-end workflow to facilitate the assessment of challenging Mendelian disorders BOSTON and LAUSANNE, Switzerland, Oct. 13, 2021 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today the launch of SOPHiA Clinical Exome Solution v3, a new genomic application that offers enhanced probe...

More community healthcare needed in COVID-19 planning as chronic disease rates pressure hospitals

Allied health experts call for more community-based care models to cope with COVID surge 'Long COVID' shown to affect one in four people who catch the virus, leading to an increase in chronic disease sufferers and the need for more rehabilitation services. The UK now has two million cases of the syndrome, Australia has no plan to...

AUM Biosciences announces closing of USD $27Million in a “Series A” Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies

SINGAPORE, Oct. 13, 2021 /PRNewswire/ -- AUM Biosciences (AUM) today announced the successful completion of USD $27 million series A funding round. This will fuel AUM's vision of developing a world class biotech pipeline focused on drugging what many consider as the undruggable targets, as well as addressing the need to delay and overcome resistance to targeted drugs in...

Accelerate Innovation Towards the Future,SAB of Winhealth Pharma Formally Established

HANGZHOU, China, Oct. 12, 2021  /PRNewswire/ -- On October 12, 2021, Hong Kong Winhealth Pharma Group, (hereinafter referred to as "Winhealth Pharma") announced the formal establishment of its Scientific Advisory Board (SAB), aiming to further expand and optimize the Group's strategic layout in medical innovation, drug research & development, and other fields. With the help of SAB, Winhealth Pharma...